Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127741281 | 12774128 | 1 | I | 20160727 | 20160914 | 20160923 | 20160923 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076549 | BRISTOL MYERS SQUIBB | 51.00 | YR | M | Y | 0.00000 | 20160923 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127741281 | 12774128 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 15 MG, QD | U | 21436 | 15 | MG | TABLET | QD | |||||
| 127741281 | 12774128 | 2 | SS | LEPONEX | CLOZAPINE | 1 | Oral | 100 MG, TID | U | 0 | 100 | MG | TID | ||||||
| 127741281 | 12774128 | 3 | C | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 0.6 MG, QD | 1.8 | MG | U | 0 | .6 | MG | QD | ||||
| 127741281 | 12774128 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | 0 | ||||||||||
| 127741281 | 12774128 | 5 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127741281 | 12774128 | 6 | C | TRIATEC /00116401/ | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 127741281 | 12774128 | 7 | C | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 127741281 | 12774128 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127741281 | 12774128 | 1 | Schizoaffective disorder |
| 127741281 | 12774128 | 2 | Schizoaffective disorder |
| 127741281 | 12774128 | 3 | Type 2 diabetes mellitus |
| 127741281 | 12774128 | 4 | Diabetes mellitus |
| 127741281 | 12774128 | 5 | Product used for unknown indication |
| 127741281 | 12774128 | 6 | Product used for unknown indication |
| 127741281 | 12774128 | 7 | Product used for unknown indication |
| 127741281 | 12774128 | 8 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127741281 | 12774128 | HO |
| 127741281 | 12774128 | OT |
| 127741281 | 12774128 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127741281 | 12774128 | Agitation | |
| 127741281 | 12774128 | Bradycardia | |
| 127741281 | 12774128 | Coma | |
| 127741281 | 12774128 | Confusional state | |
| 127741281 | 12774128 | Drug interaction | |
| 127741281 | 12774128 | Hypotension | |
| 127741281 | 12774128 | Hypothermia | |
| 127741281 | 12774128 | Insomnia | |
| 127741281 | 12774128 | Overdose | |
| 127741281 | 12774128 | Salivary hypersecretion | |
| 127741281 | 12774128 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127741281 | 12774128 | 3 | 20160725 | 20160731 | 0 |